Literature DB >> 8325028

Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.

J Mestecky1, M Tomana, P A Crowley-Nowick, Z Moldoveanu, B A Julian, S Jackson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8325028     DOI： 10.1159/000422410

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  59 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase.

Authors:  Tongzhong Ju; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-03       Impact factor: 11.205

3.  Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

Authors:  M Shimizu; N P Nikolov; K Ueno; K Ohta; R M Siegel; A Yachie; F Candotti
Journal:  Clin Immunol       Date:  2011-10-19       Impact factor: 3.969

4.  Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Authors:  Michelle M Gomes; Hitoshi Suzuki; Monica T Brooks; Milan Tomana; Zina Moldoveanu; Jiri Mestecky; Bruce A Julian; Jan Novak; Andrew B Herr
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

5.  Naturally occurring structural isomers in serum IgA1 o-glycosylation.

Authors:  Kazuo Takahashi; Archer D Smith; Knud Poulsen; Mogens Kilian; Bruce A Julian; Jiri Mestecky; Jan Novak; Matthew B Renfrow
Journal:  J Proteome Res       Date:  2011-12-29       Impact factor: 4.466

6.  Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.

Authors:  Toshikazu Nishie; Osamu Miyaishi; Haruhito Azuma; Akihiko Kameyama; Chie Naruse; Noriyoshi Hashimoto; Hitoshi Yokoyama; Hisashi Narimatsu; Takashi Wada; Masahide Asano
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

7.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

Authors:  Hitoshi Suzuki; Run Fan; Zhixin Zhang; Rhubell Brown; Stacy Hall; Bruce A Julian; W Winn Chatham; Yusuke Suzuki; Robert J Wyatt; Zina Moldoveanu; Jeannette Y Lee; James Robinson; Milan Tomana; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

8.  Analyzing antibody activity in IgA nephropathy.

Authors:  Richard J Glassock
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

Review 9.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

10.  Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.

Authors:  Jennifer S Moore; Rose Kulhavy; Milan Tomana; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Stacy Hall; Mogens Kilian; Knud Poulsen; Jiri Mestecky; Bruce A Julian; Jan Novak
Journal:  Mol Immunol       Date:  2007-02-02       Impact factor: 4.407
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.